We are live on
!
Find out more
CGPCS
Capital Group Private Client Services Portfolio holdings
AUM
$5.93B
1-Year Est. Return
27.73%
This Fund
S&P 500
This Quarter
Est. Return
+16.6%
1 Year Est. Return
+27.73%
3 Year Est. Return
+92.46%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.5B
AUM Growth
+$1.3B
(+13%)
Cap. Flow
-$20.4M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
36.18%
Holding
288
New
13
Increased
93
Reduced
157
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$36.4M |
| 2 |
Capital Group Dividend Growers ETF
CGDG
|
+$33.2M |
| 3 |
Amgen
AMGN
|
+$31.2M |
| 4 |
Mondelez International
MDLZ
|
+$21.2M |
| 5 |
CGGE
Capital Group Global Equity ETF
CGGE
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$49.2M |
| 2 |
AbbVie
ABBV
|
+$33.4M |
| 3 |
Ametek
AME
|
+$28.1M |
| 4 |
Apple
AAPL
|
+$27.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$25.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Industrials | 12.18% |
| 3 | Financials | 10.43% |
| 4 | Communication Services | 8.9% |
| 5 | Consumer Discretionary | 7.09% |
Similar funds
AL
BTCPP
CAG
WAM
VAM
BP
TCM
GFM
Capital Group Private Client Services's Q2 2025 Portfolio in Review
As of Q2 2025, Capital Group Private Client Services held 288 positions worth $11.5B, up 13% from $10.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Capital Group Private Client Services's Q2 2025 filing shows 13 new, 93 increased, 157 reduced and 9 closed positions. Its largest new stake was Roblox: 259,611 shares worth $27.3M. The largest sale was Regeneron Pharmaceuticals, an estimated $49.2M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.
- Capital Group Private Client Services's largest Q2 2025 buy was Roblox: 259,611 shares worth $27.3M.
- Capital Group Private Client Services added most to Vertex Pharmaceuticals in Q2 2025, an estimated $36.4M increase.
- Capital Group Private Client Services's biggest Q2 2025 reduction was Regeneron Pharmaceuticals, cutting an estimated $49.2M.
- Capital Group Private Client Services fully exited Discover Financial Services in Q2 2025, selling an estimated $12.1M.
- Capital Group Private Client Services's ten largest holdings make up 36% of its $11.5B portfolio in Q2 2025.
- Capital Group Private Client Services opened 13 new positions and closed 9 in Q2 2025.
- Capital Group Private Client Services's portfolio value rose 13% quarter-over-quarter to $11.5B.
Based on Capital Group Private Client Services's 13F filing for Q2 2025, filed 13 Aug 2025.